Klaravich Stables' Randomized fell just short of an Eclipse Award honor in 2023, finishing second in voting to Pretty Mischievous for champion 3-year-old filly. But if she can produce the kind of ...
SWOG 1815: A phase III randomized trial of gemcitabine, cisplatin, and nab-paclitaxel versus gemcitabine and cisplatin in newly diagnosed, advanced biliary tract cancers. This is an ASCO Meeting ...
So far, 2025 has been a 50-50 year for the 5-year-old mare Randomized . Klaravich Stables' daughter of Nyquist is a multiple grade 1 winner, but she has turned in four efforts that can be categorized ...
If there’s one type of fat I fear, it’s visceral fat. Not the jiggly stuff under your skin—which I know our egos and vanity love to hate—but the fat you can’t see. The kind that wraps itself around ...
OlympiA: A phase III, multicenter, randomized, placebo-controlled trial of adjuvant olaparib after (neo)adjuvant chemotherapy in patients with germline BRCA1/2 mutations and high-risk HER2-negative ...
An expert from the FDA explained the benefits and limitations of these two clinical trial formats and how the cancer field can learn from both. The use of single-arm trials, in which all patients ...
From spring to fall, from maiden victory to Breeders’ Cup runner-up, Randomized delivered an exceptional 2023 campaign worthy of Eclipse Award consideration as outstanding 3-year-old filly. Randomized ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results